查看购物车
  • Traditional Chinese
  • English
  • Japanese
封面
市场调查报告书
商品编码
1933100

全球女性用荷尔蒙平衡和经期健康产品市场预测（至2032年）：按产品、配方、成分类型、分销管道、应用、最终用户和地区划分

Women's Hormonal Balance & Menstrual Wellness Products Market Forecasts to 2032 - Global Analysis By Product, Formulation, Ingredient Type, Distribution Channel, Application, End User and By Geography
出版日期: | 出版商: Stratistics Market Research Consulting | 英文 | 商品交期: 2-3个工作天内

价格

根据 Stratistics MRC 的研究，预计到 2025 年，全球女性用荷尔蒙平衡和月经健康产品市场价值将达到 50.1 亿美元，到 2032 年将达到 84.3 亿美元，预测期内复合年增长率为 7.7%。

女性用荷尔蒙平衡和经期健康产品是指旨在支持荷尔蒙调节、缓解经期不适并维护女性在各个生命阶段整体生殖健康的消费者健康和保健解决方案。这些产品针对月经症候群 (PMS)、经痛、月经、更年期症状、情绪波动和精力不足等问题。此类别包括膳食补充剂、机能性食品、饮料、草药配方和外用补充剂，它们利用维生素、矿物质、植物萃取物和益生菌，安全地促进荷尔蒙平衡、缓解不适并提高生活品质。这些产品迎合了现代生活方式和全球对预防性医疗保健的需求。

荷尔蒙失调症呈上升趋势

现代生活方式、压力、不良饮食习惯以及环境中的内分泌干扰物，导致育龄女性以及更年期和闭经后女性的荷尔蒙健康问题日益增多。人们对荷尔蒙相关疾病的认识不断提高，促使女性寻求预防性和长期的健康解决方案。医疗保健专业人员也越来越多地推荐营养保健品、机能性食品和草药配方作为传统治疗方法的补充。诊断工具的进步和数位健康平台的普及使得荷尔蒙异常的早期检测成为可能。社群媒体上关于月经健康和荷尔蒙健康的讨论活性化，正在减少社会偏见，并促进相关产品的使用。随着女性越来越重视整体性和自我管理的健康，市场需求持续稳定成长。

科学检验有限

许多产品依赖传统或草药成分，但缺乏大规模、同行评审的科学研究来支持​​其功效。监管机构通常要求提供可靠的证据来支持健康声明，这给製造商带来了合规方面的挑战。调查方法的不一致和成分品质的差异进一步加剧了功效检验。缺乏标准化的临床数据会削弱医疗专业人员和谨慎消费者的信任。由于成本高昂且监管复杂，小规模品牌往往难以资金筹措长期临床试验的资金。因此，缺乏科学支持会延缓产品获得市场认可和广泛的机构接受。

扩展到停经前期和更年期

处于更年期这一人生阶段的女性越来越倾向于寻求非荷尔蒙、天然的解决方案来应对潮热、情绪波动、疲劳和睡眠障碍等症状。预期寿命的延长和女性人口老化正在扩大全球目标消费群体。各大品牌正不断创新，研发出能够支持荷尔蒙平衡、骨骼健康和情绪健康的专业配方。人们对更年期相关挑战的讨论日益增多，这推动了相关知识的普及和产品的使用。医疗保健专业人员也越来越多地建议在药物治疗之外，结合生活方式和营养疗法。这种转变使企业能够丰富其产品系列，并加强与客户参与。

仿冒品的兴起

不受监管的线上市场和非正规通路使得仿冒品很容易进入供应链。这些产品往往缺乏品管、准确的标籤和安全的成分浓度。仿冒品会削弱消费者的信任，并威胁合法製造商的品牌声誉。与欺诈性和标籤错误的保健品相关的健康风险也可能导致整个行业受到更严格的监管审查。为了解决这个问题，企业必须在防伪技术和供应链透明度方面投入大量资金。

新冠疫情的影响：

新冠疫情对女性用荷尔蒙平衡和经期健康产品市场产生了复杂的影响。疫情初期的封锁措施扰乱了生产、原料采购和实体零售通路。然而，人们对免疫力、心理健康和整体健康的日益关注，带动了对荷尔蒙平衡和经期健康产品的需求成长。疫情期间压力造成的荷尔蒙失衡进一步刺激了消费者的需求。随着消费者转向线上购物，电商平台经历了快速成长。品牌加速推动数位化行销和远端医疗整合，以维持客户参与。疫情后，韧性、全通路策略和在地化生产已成为关键优先事项。

预计在预测期内，片剂和胶囊剂型将占据最大的市场份额。

由于片剂和胶囊剂型相比液体剂型具有服用方便、剂量控制精准、保质期长等优点，预计在预测期内将占据最大的市场份额。药片和胶囊剂型是维生素、矿物质、益生菌和草药萃取物的常用给药方式。製造商青睐这种剂型，是因为它扩充性生产且成本效益高。消费者也认为胶囊剂型便于携带，是日常服用补充剂的理想选择。胶囊封装技术的进步提高了产品的生物利用度和吸收率。

在预测期内，线上零售板块将呈现最高的复合年增长率。

预计在预测期内，线上零售领域将保持最高的成长率，因为网路普及率和智慧型手机使用量的不断提高正在改变女性获取健康产品的方式。线上平台提供隐私保护、丰富的产品选择和深入的教育内容，这在购买月经和荷尔蒙健康产品时尤其重要。订阅模式和个人化产品推荐正在提高客户维繫。网红行销和数位行销宣传活动正在加速线上使用量的成长。跨境电商也帮助品牌触达尚未开发的市场。

占比最大的地区：

由于消费者健康意识高，且积极主动地进行健康管理，预计北美将在预测期内占据最大的市场份额。越来越多的女性寻求具有科学依据的膳食补充剂和功能性健康产品。成熟品牌的强大影响力以及持续的产品创新正在推动市场扩张。完善的法规结构有助于建立消费者对产品安全性和品质的信任。此外，数位健康科技和订阅式健康服务的广泛应用也使该地区受益匪浅。

年复合成长率最高的地区：

在预测期内，亚太地区预计将实现最高的复合年增长率，这主要得益于女性健康意识的提高和可支配收入的增加。在印度、中国和日本等国家，膳食补充剂和草药保健方案的接受度不断提高。人们对传统医疗体系的文化亲和性也促进了产品的普及。政府为促进女性健康和营养而采取的措施将进一步推动市场成长。零售网路和电子商务平台的扩张也提高了产品的可及性。

免费客製化服务：

购买此报告的客户可享有以下免费自订选项之一：

  • 公司概况
    • 对其他市场参与者（最多 3 家公司）进行全面分析
    • 主要企业SWOT分析（最多3家公司）
  • 区域细分
    • 根据客户要求，对主要国家进行市场估算和预测，并计算复合年增长率（註：可行性需确认）。
  • 竞争标竿分析
    • 基于产品系列、地域覆盖范围和策略联盟对主要参与者进行基准分析

目录

第一章执行摘要

第二章 前言

  • 概括
  • 相关利益者
  • 调查范围
  • 调查方法
  • 研究材料

第三章 市场趋势分析

  • 司机
  • 抑制因素
  • 机会
  • 威胁
  • 产品分析
  • 应用分析
  • 终端用户分析
  • 新兴市场
  • 新冠疫情的感染疾病

第四章 波特五力分析

  • 供应商的议价能力
  • 买方的议价能力
  • 替代品的威胁
  • 新进入者的威胁
  • 竞争对手之间的竞争

5. 全球女性用荷尔蒙平衡与经期健康产品市场（依产品分类）

  • 荷尔蒙平衡补充剂
    • 植物雌激素补充剂
    • 黄体素补充剂
    • DHEA/肾上腺支持
    • 草本/植物混合物
    • Omega-3营养复合物
  • 经期健康产品
    • 缓解经前症候群/月经疼痛
    • 情绪和能量支持补充剂
    • 激素追踪设备和应用程式
    • 月经卫生用品
    • 穿戴式诊断垫
  • 机能性食品和饮料
  • 荷尔蒙疗法和医疗设备

6. 全球女性用荷尔蒙平衡与经期健康产品市场（依配方划分）

  • 片剂和胶囊
  • 软糖/咀嚼片
  • 粉末和饮料冲剂
  • 液体和糖浆
  • 贴片和创新配方

7. 全球女性用荷尔蒙平衡与经期健康产品市场（按成分类型划分）

  • 维生素和矿物质
  • 草本萃取物/适应原
  • 益生菌
  • Omega-3脂肪酸
  • 特殊化合物

8. 全球女性用荷尔蒙平衡和经期健康产品市场（按分销管道划分）

  • 线上零售
  • 药房和药品商店
  • 超级市场和大卖场
  • 专业保健食品店
  • 订阅服务

9. 全球女性用荷尔蒙平衡与经期健康产品市场（按应用领域划分）

  • 经前症候群症状支持
  • 荷尔蒙平衡调整
  • 生育和週期管理支持
  • 更年期和围闭经支持
  • 情绪和精力提升
  • 缓解疼痛和肿胀

10. 全球女性用荷尔蒙平衡和经期健康产品市场（按最终用户划分）

  • 青春期/青少年
  • 育龄妇女
  • 闭经妇女
  • 闭经和停经后妇女
  • 医疗保健提供者和医疗机构
  • 其他的

11. 全球女性用荷尔蒙平衡与经期健康产品市场（按地区划分）

  • 北美洲
    • 我们
    • 加拿大
    • 墨西哥
  • 欧洲
    • 德国
    • 英国
    • 义大利
    • 法国
    • 西班牙
    • 其他欧洲
  • 亚太地区
    • 日本
    • 中国
    • 印度
    • 澳洲
    • 纽西兰
    • 韩国
    • 亚太其他地区
  • 南美洲
    • 阿根廷
    • 巴西
    • 智利
    • 其他南美国家
  • 中东和非洲
    • 沙乌地阿拉伯
    • 阿拉伯聯合大公国
    • 卡达
    • 南非
    • 其他中东和非洲地区

第十二章 重大进展

  • 协议、伙伴关係、合作和合资企业
  • 併购
  • 新产品发布
  • 业务拓展
  • 其他关键策略

第十三章：企业概况

  • Amway
  • Swisse Wellness
  • GNC Holdings
  • Vitabiotics
  • Herbalife International of America
  • NOW Foods
  • Nature's Bounty
  • Pure Encapsulations
  • Pharmavite LLC
  • Garden of Life
  • USANA Health Sciences
  • Archer Daniels Midland Company
  • GlaxoSmithKline
  • RBK Nutraceuticals
  • MetP Pharma AG
Product Code: SMRC33668

According to Stratistics MRC, the Global Women's Hormonal Balance & Menstrual Wellness Products Market is accounted for $5.01 billion in 2025 and is expected to reach $8.43 billion by 2032 growing at a CAGR of 7.7% during the forecast period. Women's Hormonal Balance and Menstrual Wellness Products refer to consumer health and wellness solutions designed to support hormonal regulation, menstrual comfort, and overall reproductive well-being across different life stages. These products address concerns such as PMS, cramps, cycle irregularity, menopause symptoms, mood changes, and energy levels. The category includes supplements, functional foods, beverages, herbal formulations, and topical aids that use vitamins, minerals, botanicals, and probiotics to promote balance, alleviate discomfort, and enhance daily quality of life safely for modern lifestyles and preventive care needs globally.

Market Dynamics:

Driver:

Growing prevalence of hormonal disorders

Modern lifestyles, stress, poor dietary habits, and environmental endocrine disruptors are contributing to rising hormonal health issues across reproductive-age and perimenopausal women. Greater awareness of hormone-related symptoms has encouraged women to seek preventive and long-term wellness solutions. Healthcare professionals are increasingly recommending nutraceuticals, functional foods, and herbal formulations as complementary approaches to conventional treatments. Improved diagnostic tools and digital health platforms are also enabling earlier identification of hormonal irregularities. Growing discussions around menstrual health and hormonal wellness on social media are reducing stigma and boosting product adoption. As women prioritize holistic and self-managed healthcare, market demand continues to expand steadily.

Restraint:

Limited scientific validation

Several products rely on traditional or herbal ingredients that have limited large-scale, peer-reviewed scientific studies supporting their efficacy. Regulatory authorities often demand robust evidence to substantiate health claims, creating compliance challenges for manufacturers. Inconsistent research methodologies and varying ingredient quality further complicate validation efforts. This lack of standardized clinical data can reduce trust among healthcare practitioners and cautious consumers. Smaller brands often struggle to fund long-term clinical trials due to high costs and regulatory complexity. As a result, limited scientific backing may slow market credibility and wider institutional acceptance.

Opportunity:

Expansion into perimenopause & menopause

Women in this life stage increasingly seek non-hormonal and natural solutions to manage symptoms such as hot flashes, mood swings, fatigue, and sleep disturbances. Rising life expectancy and an aging female population are enlarging the target consumer base globally. Brands are innovating with targeted formulations that support hormonal transitions, bone health, and emotional well-being. Increased openness in discussing menopause-related challenges is improving awareness and product uptake. Healthcare providers are also more willing to recommend lifestyle-based and nutritional interventions alongside medical treatments. This shift is enabling companies to diversify portfolios and strengthen long-term customer engagement.

Threat:

Rise of counterfeit products

Unregulated online marketplaces and informal distribution channels make it easier for fake products to enter the supply chain. These products often lack quality control, accurate labeling, or safe ingredient concentrations. Counterfeits can undermine consumer trust and damage brand reputation across legitimate manufacturers. Health risks associated with adulterated or mislabeled supplements may also invite stricter regulatory scrutiny for the entire sector. Companies must invest heavily in authentication technologies and supply chain transparency to combat this issue.

Covid-19 Impact:

The COVID-19 pandemic had a mixed impact on the women's hormonal balance and menstrual wellness products market. Initial lockdowns disrupted manufacturing, raw material sourcing, and physical retail distribution channels. However, heightened focus on immunity, mental health, and overall wellness led to increased interest in hormonal and menstrual health products. Stress-induced hormonal irregularities during the pandemic further boosted consumer demand. E-commerce platforms experienced rapid growth as consumers shifted to online purchasing. Brands accelerated digital marketing and telehealth collaborations to maintain customer engagement. Post-pandemic, resilience, omnichannel strategies, and localized production have become key priorities.

The tablets & capsules segment is expected to be the largest during the forecast period

The tablets & capsules segment is expected to account for the largest market share during the forecast period, driven by ease of consumption, precise dosage control, and longer shelf life compared to liquid formats. Tablets and capsules are widely preferred for delivering vitamins, minerals, probiotics, and herbal extracts. Manufacturers favor this format due to scalable production and cost efficiency. Consumers also associate capsules with convenience and portability for daily supplementation. Advances in encapsulation technology are improving bioavailability and absorption rates.

The online retail segment is expected to have the highest CAGR during the forecast period

Over the forecast period, the online retail segment is predicted to witness the highest growth rate, due to increased internet penetration and smartphone usage are transforming how women access wellness products. Online platforms offer privacy, product variety, and detailed educational content, which is particularly important for menstrual and hormonal health purchases. Subscription-based models and personalized product recommendations are enhancing customer retention. Influencer marketing and digital awareness campaigns are accelerating online adoption. Cross-border e-commerce is also enabling brands to reach underserved markets.

Region with largest share:

During the forecast period, the North America region is expected to hold the largest market share, due to high consumer awareness and proactive health management behaviors. Women increasingly seek science-backed supplements and functional wellness products. Strong presence of established brands and continuous product innovation support market expansion. Advanced regulatory frameworks help build consumer confidence in product safety and quality. The region also benefits from widespread digital health adoption and subscription-based wellness services.

Region with highest CAGR:

Over the forecast period, the Asia Pacific region is anticipated to exhibit the highest CAGR, owing to rising awareness of women's health issues and increasing disposable income. Countries such as India, China, and Japan are witnessing growing acceptance of nutraceuticals and herbal wellness solutions. Cultural familiarity with traditional medicine systems supports product adoption. Government initiatives promoting women's health and nutrition further strengthen market growth. Expanding retail networks and e-commerce platforms improve product accessibility.

Key players in the market

Some of the key players in Women's Hormonal Balance & Menstrual Wellness Products Market include Amway, Swisse Wellness, GNC Holdings, Vitabiotics, Herbalife International of America, NOW Foods, Nature's Bounty, Pure Encapsulations, Pharmavite LLC, Garden of Life, USANA Health Sciences, Archer Daniels Midland Company, GlaxoSmithKline, RBK Nutraceuticals, MetP Pharma AG.

Key Developments:

In January 2026, GSK plc announced that it has entered a definitive agreement to acquire RAPT Therapeutics, clinical-stage biopharmaceutical company dedicated to developing novel therapies for patients living with inflammatory and immunologic diseases. The acquisition includes ozureprubart, a long-acting anti-immunoglobulin E (IgE) monoclonal antibody, currently in phase IIb clinical development for prophylactic protection against food allergens.

In March 2025, ADM and Mitsubishi Corporation announced that both companies have signed a non-binding memorandum of understanding to form a strategic alliance to explore potential areas of future collaboration across the agriculture value chain. Together, ADM and MC are committed to creating value and driving solutions that will help shape the future of the global agriculture value chain.

Products Covered:

  • Hormonal Balance Supplements
  • Menstrual Wellness Products
  • Functional Foods & Beverages
  • Hormonal Therapies & Medical Devices

Formulations Covered:

  • Tablets & Capsules
  • Gummies & Chewables
  • Powders & Drink Mixes
  • Liquids & Syrups
  • Patches & Innovative Formats

Ingredient Types Covered:

  • Vitamins & Minerals
  • Herbal Extracts & Adaptogens
  • Probiotics
  • Omega-3 Fatty Acids
  • Specialty Compounds

Distribution Channels Covered:

  • Online Retail
  • Pharmacies & Drug Stores
  • Supermarkets & Hypermarkets
  • Specialty Health Stores
  • Subscription Services

Applications Covered:

  • PMS Symptom Support
  • Hormonal Balance Regulation
  • Fertility & Cycle Tracking Support
  • Menopause & Perimenopause Support
  • Mood & Energy Enhancement
  • Pain & Bloating Relief

End Users Covered:

  • Adolescents & Teens
  • Women of Reproductive Age
  • Perimenopausal Women
  • Menopausal & Postmenopausal Women
  • Healthcare Providers & Clinics
  • Other End Users

Regions Covered:

  • North America
    • US
    • Canada
    • Mexico
  • Europe
    • Germany
    • UK
    • Italy
    • France
    • Spain
    • Rest of Europe
  • Asia Pacific
    • Japan
    • China
    • India
    • Australia
    • New Zealand
    • South Korea
    • Rest of Asia Pacific
  • South America
    • Argentina
    • Brazil
    • Chile
    • Rest of South America
  • Middle East & Africa
    • Saudi Arabia
    • UAE
    • Qatar
    • South Africa
    • Rest of Middle East & Africa

What our report offers:

  • Market share assessments for the regional and country-level segments
  • Strategic recommendations for the new entrants
  • Covers Market data for the years 2024, 2025, 2026, 2028, and 2032
  • Market Trends (Drivers, Constraints, Opportunities, Threats, Challenges, Investment Opportunities, and recommendations)
  • Strategic recommendations in key business segments based on the market estimations
  • Competitive landscaping mapping the key common trends
  • Company profiling with detailed strategies, financials, and recent developments
  • Supply chain trends mapping the latest technological advancements

Free Customization Offerings:

All the customers of this report will be entitled to receive one of the following free customization options:

  • Company Profiling
    • Comprehensive profiling of additional market players (up to 3)
    • SWOT Analysis of key players (up to 3)
  • Regional Segmentation
    • Market estimations, Forecasts and CAGR of any prominent country as per the client's interest (Note: Depends on feasibility check)
  • Competitive Benchmarking
    • Benchmarking of key players based on product portfolio, geographical presence, and strategic alliances

Table of Contents

1 Executive Summary

2 Preface

  • 2.1 Abstract
  • 2.2 Stake Holders
  • 2.3 Research Scope
  • 2.4 Research Methodology
    • 2.4.1 Data Mining
    • 2.4.2 Data Analysis
    • 2.4.3 Data Validation
    • 2.4.4 Research Approach
  • 2.5 Research Sources
    • 2.5.1 Primary Research Sources
    • 2.5.2 Secondary Research Sources
    • 2.5.3 Assumptions

3 Market Trend Analysis

  • 3.1 Introduction
  • 3.2 Drivers
  • 3.3 Restraints
  • 3.4 Opportunities
  • 3.5 Threats
  • 3.6 Product Analysis
  • 3.7 Application Analysis
  • 3.8 End User Analysis
  • 3.9 Emerging Markets
  • 3.10 Impact of Covid-19

4 Porters Five Force Analysis

  • 4.1 Bargaining power of suppliers
  • 4.2 Bargaining power of buyers
  • 4.3 Threat of substitutes
  • 4.4 Threat of new entrants
  • 4.5 Competitive rivalry

5 Global Women's Hormonal Balance & Menstrual Wellness Products Market, By Product

  • 5.1 Introduction
  • 5.2 Hormonal Balance Supplements
    • 5.2.1 Phytoestrogen Supplements
    • 5.2.2 Progesterone Supplements
    • 5.2.3 DHEA & Adrenal Support
    • 5.2.4 Herbal/Botanical Blends
    • 5.2.5 Omega-3 & Nutrient Complexes
  • 5.3 Menstrual Wellness Products
    • 5.3.1 PMS & Menstrual Pain Relief
    • 5.3.2 Mood & Energy Support Supplements
    • 5.3.3 Hormone Tracking Devices & Apps
    • 5.3.4 Menstrual Hygiene Products
    • 5.3.5 Wearables & Diagnostic Pads
  • 5.4 Functional Foods & Beverages
  • 5.5 Hormonal Therapies & Medical Devices

6 Global Women's Hormonal Balance & Menstrual Wellness Products Market, By Formulation

  • 6.1 Introduction
  • 6.2 Tablets & Capsules
  • 6.3 Gummies & Chewables
  • 6.4 Powders & Drink Mixes
  • 6.5 Liquids & Syrups
  • 6.6 Patches & Innovative Formats

7 Global Women's Hormonal Balance & Menstrual Wellness Products Market, By Ingredient Type

  • 7.1 Introduction
  • 7.2 Vitamins & Minerals
  • 7.3 Herbal Extracts & Adaptogens
  • 7.4 Probiotics
  • 7.5 Omega-3 Fatty Acids
  • 7.6 Specialty Compounds

8 Global Women's Hormonal Balance & Menstrual Wellness Products Market, By Distribution Channel

  • 8.1 Introduction
  • 8.2 Online Retail
  • 8.3 Pharmacies & Drug Stores
  • 8.4 Supermarkets & Hypermarkets
  • 8.5 Specialty Health Stores
  • 8.6 Subscription Services

9 Global Women's Hormonal Balance & Menstrual Wellness Products Market, By Application

  • 9.1 Introduction
  • 9.2 PMS Symptom Support
  • 9.3 Hormonal Balance Regulation
  • 9.4 Fertility & Cycle Tracking Support
  • 9.5 Menopause & Perimenopause Support
  • 9.6 Mood & Energy Enhancement
  • 9.7 Pain & Bloating Relief

10 Global Women's Hormonal Balance & Menstrual Wellness Products Market, By End User

  • 10.1 Introduction
  • 10.2 Adolescents & Teens
  • 10.3 Women of Reproductive Age
  • 10.4 Perimenopausal Women
  • 10.5 Menopausal & Postmenopausal Women
  • 10.6 Healthcare Providers & Clinics
  • 10.7 Other End Users

11 Global Women's Hormonal Balance & Menstrual Wellness Products Market, By Geography

  • 11.1 Introduction
  • 11.2 North America
    • 11.2.1 US
    • 11.2.2 Canada
    • 11.2.3 Mexico
  • 11.3 Europe
    • 11.3.1 Germany
    • 11.3.2 UK
    • 11.3.3 Italy
    • 11.3.4 France
    • 11.3.5 Spain
    • 11.3.6 Rest of Europe
  • 11.4 Asia Pacific
    • 11.4.1 Japan
    • 11.4.2 China
    • 11.4.3 India
    • 11.4.4 Australia
    • 11.4.5 New Zealand
    • 11.4.6 South Korea
    • 11.4.7 Rest of Asia Pacific
  • 11.5 South America
    • 11.5.1 Argentina
    • 11.5.2 Brazil
    • 11.5.3 Chile
    • 11.5.4 Rest of South America
  • 11.6 Middle East & Africa
    • 11.6.1 Saudi Arabia
    • 11.6.2 UAE
    • 11.6.3 Qatar
    • 11.6.4 South Africa
    • 11.6.5 Rest of Middle East & Africa

12 Key Developments

  • 12.1 Agreements, Partnerships, Collaborations and Joint Ventures
  • 12.2 Acquisitions & Mergers
  • 12.3 New Product Launch
  • 12.4 Expansions
  • 12.5 Other Key Strategies

13 Company Profiling

  • 13.1 Amway
  • 13.2 Swisse Wellness
  • 13.3 GNC Holdings
  • 13.4 Vitabiotics
  • 13.5 Herbalife International of America
  • 13.6 NOW Foods
  • 13.7 Nature's Bounty
  • 13.8 Pure Encapsulations
  • 13.9 Pharmavite LLC
  • 13.10 Garden of Life
  • 13.11 USANA Health Sciences
  • 13.12 Archer Daniels Midland Company
  • 13.13 GlaxoSmithKline
  • 13.14 RBK Nutraceuticals
  • 13.15 MetP Pharma AG

List of Tables

  • Table 1 Global Women's Hormonal Balance & Menstrual Wellness Products Market Outlook, By Region (2024-2032) ($MN)
  • Table 2 Global Women's Hormonal Balance & Menstrual Wellness Products Market Outlook, By Product (2024-2032) ($MN)
  • Table 3 Global Women's Hormonal Balance & Menstrual Wellness Products Market Outlook, By Hormonal Balance Supplements (2024-2032) ($MN)
  • Table 4 Global Women's Hormonal Balance & Menstrual Wellness Products Market Outlook, By Phytoestrogen Supplements (2024-2032) ($MN)
  • Table 5 Global Women's Hormonal Balance & Menstrual Wellness Products Market Outlook, By Progesterone Supplements (2024-2032) ($MN)
  • Table 6 Global Women's Hormonal Balance & Menstrual Wellness Products Market Outlook, By DHEA & Adrenal Support (2024-2032) ($MN)
  • Table 7 Global Women's Hormonal Balance & Menstrual Wellness Products Market Outlook, By Herbal/Botanical Blends (2024-2032) ($MN)
  • Table 8 Global Women's Hormonal Balance & Menstrual Wellness Products Market Outlook, By Omega-3 & Nutrient Complexes (2024-2032) ($MN)
  • Table 9 Global Women's Hormonal Balance & Menstrual Wellness Products Market Outlook, By Menstrual Wellness Products (2024-2032) ($MN)
  • Table 10 Global Women's Hormonal Balance & Menstrual Wellness Products Market Outlook, By PMS & Menstrual Pain Relief (2024-2032) ($MN)
  • Table 11 Global Women's Hormonal Balance & Menstrual Wellness Products Market Outlook, By Mood & Energy Support Supplements (2024-2032) ($MN)
  • Table 12 Global Women's Hormonal Balance & Menstrual Wellness Products Market Outlook, By Hormone Tracking Devices & Apps (2024-2032) ($MN)
  • Table 13 Global Women's Hormonal Balance & Menstrual Wellness Products Market Outlook, By Menstrual Hygiene Products (2024-2032) ($MN)
  • Table 14 Global Women's Hormonal Balance & Menstrual Wellness Products Market Outlook, By Wearables & Diagnostic Pads (2024-2032) ($MN)
  • Table 15 Global Women's Hormonal Balance & Menstrual Wellness Products Market Outlook, By Functional Foods & Beverages (2024-2032) ($MN)
  • Table 16 Global Women's Hormonal Balance & Menstrual Wellness Products Market Outlook, By Hormonal Therapies & Medical Devices (2024-2032) ($MN)
  • Table 17 Global Women's Hormonal Balance & Menstrual Wellness Products Market Outlook, By Formulation (2024-2032) ($MN)
  • Table 18 Global Women's Hormonal Balance & Menstrual Wellness Products Market Outlook, By Tablets & Capsules (2024-2032) ($MN)
  • Table 19 Global Women's Hormonal Balance & Menstrual Wellness Products Market Outlook, By Gummies & Chewables (2024-2032) ($MN)
  • Table 20 Global Women's Hormonal Balance & Menstrual Wellness Products Market Outlook, By Powders & Drink Mixes (2024-2032) ($MN)
  • Table 21 Global Women's Hormonal Balance & Menstrual Wellness Products Market Outlook, By Liquids & Syrups (2024-2032) ($MN)
  • Table 22 Global Women's Hormonal Balance & Menstrual Wellness Products Market Outlook, By Patches & Innovative Formats (2024-2032) ($MN)
  • Table 23 Global Women's Hormonal Balance & Menstrual Wellness Products Market Outlook, By Ingredient Type (2024-2032) ($MN)
  • Table 24 Global Women's Hormonal Balance & Menstrual Wellness Products Market Outlook, By Vitamins & Minerals (2024-2032) ($MN)
  • Table 25 Global Women's Hormonal Balance & Menstrual Wellness Products Market Outlook, By Herbal Extracts & Adaptogens (2024-2032) ($MN)
  • Table 26 Global Women's Hormonal Balance & Menstrual Wellness Products Market Outlook, By Probiotics (2024-2032) ($MN)
  • Table 27 Global Women's Hormonal Balance & Menstrual Wellness Products Market Outlook, By Omega-3 Fatty Acids (2024-2032) ($MN)
  • Table 28 Global Women's Hormonal Balance & Menstrual Wellness Products Market Outlook, By Specialty Compounds (2024-2032) ($MN)
  • Table 29 Global Women's Hormonal Balance & Menstrual Wellness Products Market Outlook, By Distribution Channel (2024-2032) ($MN)
  • Table 30 Global Women's Hormonal Balance & Menstrual Wellness Products Market Outlook, By Online Retail (2024-2032) ($MN)
  • Table 31 Global Women's Hormonal Balance & Menstrual Wellness Products Market Outlook, By Pharmacies & Drug Stores (2024-2032) ($MN)
  • Table 32 Global Women's Hormonal Balance & Menstrual Wellness Products Market Outlook, By Supermarkets & Hypermarkets (2024-2032) ($MN)
  • Table 33 Global Women's Hormonal Balance & Menstrual Wellness Products Market Outlook, By Specialty Health Stores (2024-2032) ($MN)
  • Table 34 Global Women's Hormonal Balance & Menstrual Wellness Products Market Outlook, By Subscription Services (2024-2032) ($MN)
  • Table 35 Global Women's Hormonal Balance & Menstrual Wellness Products Market Outlook, By Application (2024-2032) ($MN)
  • Table 36 Global Women's Hormonal Balance & Menstrual Wellness Products Market Outlook, By PMS Symptom Support (2024-2032) ($MN)
  • Table 37 Global Women's Hormonal Balance & Menstrual Wellness Products Market Outlook, By Hormonal Balance Regulation (2024-2032) ($MN)
  • Table 38 Global Women's Hormonal Balance & Menstrual Wellness Products Market Outlook, By Fertility & Cycle Tracking Support (2024-2032) ($MN)
  • Table 39 Global Women's Hormonal Balance & Menstrual Wellness Products Market Outlook, By Menopause & Perimenopause Support (2024-2032) ($MN)
  • Table 40 Global Women's Hormonal Balance & Menstrual Wellness Products Market Outlook, By Mood & Energy Enhancement (2024-2032) ($MN)
  • Table 41 Global Women's Hormonal Balance & Menstrual Wellness Products Market Outlook, By Pain & Bloating Relief (2024-2032) ($MN)
  • Table 42 Global Women's Hormonal Balance & Menstrual Wellness Products Market Outlook, By End User (2024-2032) ($MN)
  • Table 43 Global Women's Hormonal Balance & Menstrual Wellness Products Market Outlook, By Adolescents & Teens (2024-2032) ($MN)
  • Table 44 Global Women's Hormonal Balance & Menstrual Wellness Products Market Outlook, By Women of Reproductive Age (2024-2032) ($MN)
  • Table 45 Global Women's Hormonal Balance & Menstrual Wellness Products Market Outlook, By Perimenopausal Women (2024-2032) ($MN)
  • Table 46 Global Women's Hormonal Balance & Menstrual Wellness Products Market Outlook, By Menopausal & Postmenopausal Women (2024-2032) ($MN)
  • Table 47 Global Women's Hormonal Balance & Menstrual Wellness Products Market Outlook, By Healthcare Providers & Clinics (2024-2032) ($MN)
  • Table 48 Global Women's Hormonal Balance & Menstrual Wellness Products Market Outlook, By Other End Users (2024-2032) ($MN)

Note: Tables for North America, Europe, APAC, South America, and Middle East & Africa Regions are also represented in the same manner as above.